CRN Recognizes HYCU® as a Cloud 100 Company for 2023

CRN Recognizes HYCU® as a Cloud 100 Company for 2023

Innovation across Hybrid and Multicloud Data Protection as a Service with Award-Winning Solutions Drives Partner and Reseller Success to Secure Latest......

Destination XL Group, Inc. Names Dara Pauker Chief

Destination XL Group, Inc. Names Dara Pauker Chief

CANTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of men’s Big + Tall......

Asensus Surgical to Host Investor Day on February 21, 2023

Asensus Surgical to Host Investor Day on February 21, 2023

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing......

Daseke Names Adrianne D. Griffin Vice President, Investor

Daseke Names Adrianne D. Griffin Vice President, Investor

Newly created role with a dedicated proven leader facilitates enhanced communication of the Company’s shareholder value proposition......

Nogin Announces Jonathan Huberman as Chairman and Chief

Nogin Announces Jonathan Huberman as Chairman and Chief

TUSTIN, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nogin (“Nogin” or the “Company”), a leading provider of innovative Commerce-as-a-Service (CaaS)......

Duolingo to Announce Fourth Quarter and Full Year 2022

Duolingo to Announce Fourth Quarter and Full Year 2022

PITTSBURGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile learning platform, will announce its results for......

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief

Rob Brown to continue serving as a member of the Board of Directors and as a special advisor to the Company......

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data

Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better......

  • 1
  • ...
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • menu
    menu